Lupin Shares Gain on ‘No Observation’ Certificate from USFDA Inspection
Lupin shares rose in early trading on March 14 after receiving a “no observation” certificate from the US Food and Drug Administration (USFDA). At 9:16...
Tag : Lupin
Lupin Shares Up 8% After Reporting Q2 Profit of Rs 129.7 Crore
Lupin shares rose more than 8% intraday on November 10, the day after the company reported its earnings and turned a profit in the quarter...
Lupin Partners with Global Agencies to Support TB Prevention Treatment Initiatives
On Friday, Pharmaceutical company Lupin said that it has partnered with Unitaid, the Aurum Institute, the Clinton Health Access Initiative (CHAI) and other global procurement...
Lupin’s Generic HIV Drug Darunavir Gets USFDA Nod for Marketing in the US
On Tuesday, drug company Lupin said it had received approval from the US health regulator USFDA to market Darunavir Tablets in the American market. These...
Lupin Launches Oral Drug Sildenafil for Erectile Dysfunction
On Thursday, India-based Global pharmaceutical company Lupin Limited announced the launch of Sildenafil for oral suspension, 10 mg/mL, after receiving approval from the United States...
Lupin Gets Generic Drug Approval from USFDA
Drugmaker Lupin said on Wednesday it had received preliminary approval from US health regulators to sell Ivacaftor tablets for cystic fibrosis in the US. In...
USFDA Approves Lupin as A Generic Drug
Pharmaceutical company Lupin said on Monday it had received approval from US health regulators to market its Tenofovir Alafenamide tablets to treat chronic hepatitis B...
India’s Top Pharma Majors in Talks to Buy Pharmarack
India’s top pharmaceutical majors, including Sun Pharma, Cadila Healthcare, Lupin, and Torrent Pharma, are in talks to acquire business-to-business healthcare platform Pharmarack, according to multiple...
Lupin Outlook for the Week (July 27,2020 – July 31, 2020)
EquityPandit’s Outlook for Lupin for the week (July 27,2020 – July 31, 2020) LUPIN: BSE: 500257| NSE: LUPIN| ISIN: INE326A01037| SECTOR: PHARMA Stock closed the...
Lupin Outlook for the Week (July 20,2020 – July 24, 2020)
EquityPandit’s Outlook for Lupin for the week (July 20,2020 – July 24, 2020) LUPIN: BSE: 500257| NSE: LUPIN| ISIN: INE326A01037| SECTOR: PHARMA Stock closed the...